SALES of Sars sensor kits to China worth £1m helped healthcare group Osmetech cut pre-tax losses to £3.8m from £4.7m in the year to April. It expects repeat sales of the chemicals used to conduct the Sars analysis, further boosting revenue.
Create a FREE account to continue reading
Registration is a free and easy way to support our journalism.
Join our community where you can: comment on stories; sign up to newsletters; enter competitions and access content on our app.
Thank you for registering
Please refresh the page or navigate to another page on the site to be automatically logged in